Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (2 quarters reported)
$14.7M in Q2 2013 → $38.6M now. Hover for any quarter.
As reported for the quarter ended September 30, 2013. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| OP Onyx Pharmaceuticals Inc Put | 24.0% | New | 74,400 | $9.28M |
| R Rue21 Inc | 15.4% | New | 147,500 | $5.95M |
| PS Peregrine Semiconductor Corp | 15.3% | Unchanged | 658,974 | $5.91M |
| D Dell Inc Put | 14.7% | New | 413,900 | $5.69M |
| TE Transglobe Energy Corp | 9.2% | Added 22% | 450,100 | $3.54M |
| PE Pengrowth Energy Corp Put | 8.2% | Added 79% | 535,000 | $3.17M |
| OP Onyx Pharmaceuticals Inc | 7.3% | New | 22,600 | $2.82M |
| PE Pengrowth Energy Corp | 2.8% | Trimmed 59% | 183,080 | $1.08M |
| R Rue21 Inc Put | 2.1% | New | 20,000 | $807K |
| S Sprint Corp Call | 0.7% | New | 45,500 | $283K |
| YI Yongye Intl Inc | 0.2% | New | 12,858 | $80K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 1 quarters.
quarter ended September 30, 2013 · filed November 14, 2013
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| OP Onyx Pharmaceuticals Inc | New | +74,400 | +$9.28M | 24.0% |
| R Rue21 Inc | New | +147,500 | +$5.95M | 15.4% |
| D Dell Inc | New | +413,900 | +$5.69M | 14.7% |
| OP Onyx Pharmaceuticals Inc | New | +22,600 | +$2.82M | 7.3% |
| PE Pengrowth Energy Corp | Trimmed | −258,800 | −$1.53M | 2.8% |
| NG New Gold Inc Cda | Exited | −220,000 | −$1.41M | — |
| PE Pengrowth Energy Corp | Added | +235,700 | +$1.4M | 8.2% |
| R Rue21 Inc | New | +20,000 | +$807K | 2.1% |
| TE Transglobe Energy Corp | Added | +80,500 | +$633K | 9.2% |
| S Sprint Corp | New | +45,500 | +$283K | 0.7% |
Showing the 10 largest of 12 changes.
Loading...
